Explore 3 Stock Ideas & Industry Insights Download Free Report

Stocks

Denali Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights Including Completion of BLA Rolling Submission for Tividenofusp Alfa for Hunter Syndrome

Denali Therapeutics Inc. SOUTH SAN FRANCISCO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today reported financial results for the first quarter ended March 31, 2025, and provided business highlights. “The completion of our BLA submission for tividenofusp alfa represents …

EODHD | 06 May 2025

Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs

Record HEPLISAV-B® first quarter net product revenue of $65 million, representing 36% year-over-year growth Top-line results in Part 1 of Phase 1/2 shingles vaccine trial expected in Q3 2025 New pandemic influenza adjuvant program and Lyme disease vaccine programs planned to enter clinical development …

EODHD | 06 May 2025

Grocery Outlet Holding Corp. Announces First Quarter Fiscal 2025 Financial Results

Grocery Outlet, Inc. EMERYVILLE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Grocery Outlet Holding Corp. (NASDAQ: GO) ("Grocery Outlet," the "Company," "we" or "our") today announced financial results for the first quarter of fiscal 2025 ended March 29, 2025. Highlights for First Quarter Fiscal …

EODHD | 06 May 2025

Gulfport Energy Reports First Quarter 2025 Financial and Operational Results

OKLAHOMA CITY, May 06, 2025--(BUSINESS WIRE)--Gulfport Energy Corporation (NYSE: GPOR) ("Gulfport" or the "Company") today reported financial and operational results for the three months ended March 31, 2025 and provided an update on its 2025 development plan and financial position. First Quarter 2025 and …

EODHD | 06 May 2025

HALOZYME RAISES 2025 FINANCIAL GUIDANCE RANGES AND REPORTS STRONG FIRST QUARTER 2025 RESULTS

Announcing New $250M Share Repurchase Total Revenue Increased 35% YOY to $265 million and Royalty Revenue Increased 39% YOY to $168 million Net Income Increased 54% YOY to $118 million; Adjusted EBITDA Increased 40% YOY to $162 million; GAAP Diluted EPS Increased 55% YOY …

EODHD | 06 May 2025

Keros Therapeutics Reports Recent First Quarter 2025 Financial Results

LEXINGTON, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of …

EODHD | 06 May 2025

Standard BioTools Reports First Quarter 2025 Financial Results

SOUTH SAN FRANCISCO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the first quarter ended March 31, 2025. Recent Highlights: First quarter 2025 revenue of $40.8 million45% reduction in operating …

EODHD | 06 May 2025

Lantheus Announces Sale of SPECT Business to SHINE Technologies

Lantheus Holdings, Inc. Enables Lantheus to focus on innovative radiopharmaceuticals, while maximizing the value of its SPECT business SHINE will acquire products TechneLite®, NEUROLITE®, Xenon Xe-133 Gas, and Cardiolite® BEDFORD, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) …

EODHD | 06 May 2025

Lyra Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

WATERTOWN, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company developing long-acting, anti-inflammatory sinonasal implants for the treatment of chronic rhinosinusitis (CRS), today reported its financial results for the first quarter ended March …

EODHD | 06 May 2025

Mercury Systems Reports Third Quarter Fiscal 2025 Results

Mercury Systems Inc Q3 FY25 Bookings of $200.4 million; trailing-twelve-month book-to-bill of 1.1 Backlog of $1.34 billion; up4% year-over-year Q3 FY25 Revenue of $211.4 million; GAAP net loss of $19.2 million; and adjusted EBITDA of $24.7 million Operating Cash Flow of $30.0 million with …

EODHD | 06 May 2025
Support

Hi! How can we help you today?

Loading…